Monogram Health Cements Influence with Key Nashville Council Seats

NASHVILLE, TN – January 22, 2026 – In a move that solidifies its growing stature within the American healthcare landscape, Monogram Health has placed three of its top executives in key leadership positions within the influential Nashville Health Care Council. The appointments signal a significant endorsement of the company's disruptive in-home care model and position its leadership to help shape the future of healthcare from within one of the nation's most powerful industry hubs.

Monogram Health’s Co-Founder and CEO, Michael Uchrin, has been appointed to the Council’s inaugural independent Board of Directors. Concurrently, Southeast Region President David Wedemeyer was selected for the prestigious 2026 Council Fellows cohort, and James Porter, Vice President of Provider Partnerships, was elected Vice Chair of the Council’s Leadership Health Care Advisory. These roles place Monogram executives at the center of strategic discussions, leadership development, and innovation within Nashville's sprawling healthcare ecosystem.

A Seat at the Table in 'The Healthcare City'

The significance of these appointments is magnified by the stature of the Nashville Health Care Council (NHCC). Founded in 1995, the Council is the premier convener for an industry that generates a staggering $72.1 billion in local economic impact and supports over 372,000 jobs. While the NHCC explicitly does not lobby, its power lies in its ability to bring together the industry's most powerful executives to share ideas, foster innovation, and guide the strategic direction of healthcare.

By joining the board, CEO Michael Uchrin will help guide an organization that serves as the common ground for over 500 healthcare companies headquartered in the region. His two decades of experience leading health plans and provider organizations offer a critical perspective to the board's mission.

“We are proud to welcome Michael Uchrin to the Council’s inaugural independent Board of Directors as we continue to serve as a catalyst for strategic and trusted exchange, economic development, and the next generation of healthcare talent,” said Apryl Childs-Potter, CEO of the Nashville Health Care Council. “Michael Uchrin and his team bring a fresh perspective and a shared commitment to innovating and advancing the future of healthcare for the better.”

David Wedemeyer's selection for the Council Fellows program places him in an elite cohort of senior executives tasked with reimagining solutions to the industry's most pressing challenges. Similarly, James Porter's role with the Leadership Health Care Advisory will focus on cultivating the next generation of industry leaders, ensuring Monogram's perspective is embedded in the sector's talent pipeline.

The Rise of a Chronic Care Disruptor

Monogram Health's ascent has been nothing short of meteoric. Ranked by Inc. Magazine as the 3rd fastest-growing private company in the U.S. in 2024 and 7th in 2025, the company has rapidly expanded its unique care model across 36 states, serving over 200,000 patients. This growth is fueled by a model that directly confronts one of the healthcare system's most complex and costly challenges: managing patients with multiple chronic conditions.

Instead of siloing care by specialty, Monogram deploys an integrated team of nephrologists, cardiologists, endocrinologists, and behavioral health specialists directly into patients' homes. This comprehensive, personalized approach focuses on treating the whole person, addressing conditions like diabetes, chronic kidney disease, and heart failure simultaneously. The results have been dramatic, with the company reporting a 44% reduction in hospital admissions and a 52% reduction in emergency room visits for its patient population.

This value-based approach has attracted significant backing from major players in the industry. The company has raised $542 million in funding, with investors including Cigna Ventures, Humana, CVS Health Ventures, and TPG Capital. This strong financial foundation, combined with its proven clinical outcomes, has established Monogram not just as a fast-growing startup, but as a formidable force in chronic disease management.

Riding the Wave of Healthcare Transformation

The appointments come at a pivotal moment for the U.S. healthcare system, which is undergoing a profound shift toward value-based, patient-centered care. The traditional fee-for-service model is increasingly viewed as inefficient for managing long-term illness. Monogram's success is a clear indicator of the growing demand for alternatives that prioritize patient outcomes and quality of life while controlling costs.

Furthermore, the industry is seeing an accelerated move toward care delivery in the home, a trend supported by advancements in technology and a growing preference among patients and providers. Monogram's model is at the forefront of this movement, leveraging analytics and a 24/7 care team to provide sophisticated medical support outside of traditional clinical settings. This approach is particularly aligned with new initiatives from the Centers for Medicare & Medicaid Services (CMS), which are promoting innovative models for chronic care management and health equity.

By focusing on polychronic patients—a population often underserved and highly expensive within the conventional system—Monogram has tapped into a critical need. Its ability to deliver integrated, in-home care provides a blueprint for how the system can better serve its most vulnerable members.

Shaping the Future of Care Delivery

With these key roles at the NHCC, Monogram Health's leadership is now positioned to transition from successful practitioners to influential architects of industry-wide strategy. While the Council's work is educational rather than political, the ideas and best practices shared within its exclusive forums often create a ripple effect, shaping corporate strategies and indirectly influencing policy discussions across the nation.

For Monogram, this represents an opportunity to champion its philosophy of integrated, in-home care on a much larger stage. The presence of its executives on the board, in the Fellows program, and within the leadership advisory group ensures their innovative approach to chronic disease will be a central part of the conversation as Nashville's healthcare leaders plot the course for the future. The appointments are a testament to the company's remarkable growth and a clear signal that its model for managing chronic illness is becoming a benchmark for the entire industry.